ESR1 and breast carcinoma: also discovered that ER-positive/PR-positive breast cancer cell-inoculated ovary-excised mice remained metastasis-free until they were supplemented with estrogen or estrogen plus progestin (27), suggesting that hormone signaling promotes bone metastases in luminal breast cancer.